Vanadate-induced suicidal erythrocyte death

Kidney and Blood Pressure Research

Volumn 31, Issue 2, 2008, Pages 87-93

  Föller, Michael ^a   Sopjani, Mentor ^a   Mahmud, Hasan ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Calcium; Ceramide; Eryptosis; Sphingomyelinase

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; FLUO 3; LIPOCORTIN 5; PHOSPHATIDYLSERINE; VANADIC ACID;

ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PHAGOCYTE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANEMIA; APOPTOSIS; CALCIUM; ERYTHROCYTE AGING; ERYTHROCYTES; HUMANS; MICROSCOPY, FLUORESCENCE; PHOSPHATIDYLSERINES; VANADATES;

EID: 43049129678     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119704     Document Type: Article

References (56)

1. 2+ and Na,K-ATPases: short review. Braz J Med Biol Res 1988;21:1261-1267.
2. Kumar A, Corder CN: Diuretic and vasoconstrictor effects of sodium orthovanadate on the isolated perfused rat kidney. J Pharmacol Exp Ther 1980;213:85-90.
3. Grantham JJ: The renal sodium pump and vanadate. Am J Physiol 1980;239:F97-F106.
4. Higashi Y, Bello-Reuss E: Effects of sodium orthovanadate on whole kidney and single nephron function. Kidney Int 1980;18:302-308.
5. Westenfelder C, Hamburger RK, Garcia ME: Effect of vanadate on renal tubular function in rats. Am J Physiol 1981;240:F522-F529.
6. Kramer HJ, Backer A, Meyer-Lehnert H: Effects of urinary ouabain-like factors and vanadium diascorbate on calcium mobilization in porcine inner medullary collecting duct cells: comparison with the effects of ouabain and vasopressin. Am J Hypertens 1998;11:1208-1213.
7. Meyer-Lehnert H, Backer A, Kramer HJ: Inhibitors of Na,K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin. Am J Hypertens 2000;13:364-369.
8. Goldwaser I, Gefel D, Gershonov E, Fridkin M, Shechter Y: Insulin-like effects of vanadium: basic and clinical implications. J Inorg Biochem 2000;80:21-25.
9. Kiersztan A, Modzelewska A, Jarzyna R, Jagielska E, Bryla J: Inhibition of gluconeogenesis by vanadium and metformin in kidney-cortex tubules isolated from control and diabetic rabbits. Biochem Pharmacol 2002;63:1371-1382.
10. Meyerovitch J, Farfel Z, Sack J, Shechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J Biol Chem 1987;262:6658-6662.
11. Sakurai H: A new concept: the use of vanadium complexes in the treatment of diabetes mellitus. Chem Rec 2002;2:237-248.
12. Srivastava AK: Anti-diabetic and toxic effects of vanadium compounds. Mol Cell Biochem 2000;206:177-182.
13. Dafnis E, Sabatini S: Biochemistry and pathophysiology of vanadium. Nephron 1994;67:133-143.
14. Bello-Reuss EN, Grady TP, Mazumdar DC: Serum vanadium levels in chronic renal disease. Ann Intern Med 1979;91:743.
15. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F: Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005;15:195-202.
16. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-256.
17. Lang KS, Myssina S, Tanneur V, Wieder T, Huber SM, Lang F, Duranton C: Inhibition of erythrocyte cation channels and apoptosis by ethylisopropylamiloride. Naunyn Schmiedebergs Arch Pharmacol 2003;367:391-396.
18. Lang PA, Kempe DS, Akel A, Klarl BA, Eisele K, Podolski M, Hermle T, Niemoeller OM, Attanasio P, Huber SM, Wieder T, Lang F, Duranton C: Inhibition of erythrocyte 'apoptosis' by catecholamines. Naunyn Schmiedebergs Arch Pharmacol 2005;372:228-235.
19. Kaestner L, Christophersen P, Bernhardt I, Bennekou P: The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation. Bioelectrochemistry 2000;52:117-125.
20. Kaestner L, Bernhardt I: Ion channels in the human red blood cell membrane: their further investigation and physiological relevance. Bioelectrochemistry 2002;55:71-74.
21. + channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560.
22. 2+-induced erythrocyte 'apoptosis'. Cell Physiol Biochem 2004;14:241-248.
23. 2+ sensitivity of phospholipid scrambling in human red cell ghosts. Cell Calcium 1999;25:313-320.
24. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, Wieder T: Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004;11:231-243.
25. 2 in the regulation of programmed erythrocyte death. Cell Death Differ 2005;12:415-428.
26. Lang PA, Kempe DS, Tanneur V, Eisele K, Klarl BA, Myssina S, Jendrossek V, Ishii S, Shimizu T, Waidmann M, Hessler G, Huber SM, Lang F, Wieder T: Stimulation of erythrocyte ceramide formation by platelet-activating factor. J Cell Sci 2005;118:1233-1243.
27. Lang PA, Kaiser S, Myssina S, Birka C, Weinstock C, Northoff H, Wieder T, Lang F, Huber SM: Effect of Vibrio parahaemolyticus haemolysin on human erythrocytes. Cell Microbiol 2004;6:391-400.
28. Lang PA, Huober J, Bachmann C, Kempe DS, Sobiesiak M, Akel A, Niemoeller OM, Dreischer P, Eisele K, Klarl BA, Gulbins E, Lang F, Wieder T: Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cell Physiol Biochem 2006;18:151-164.
29. Akel A, Hermle T, Niemoeller OM, Kempe DS, Lang PA, Attanasio P, Podolski M, Wieder T, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by chlorpromazine. Eur J Pharmacol 2006;532:11-17.
30. Niemoeller OM, Akel A, Lang PA, Attanasio P, Kempe DS, Hermle T, Sobiesiak M, Wieder T, Lang F: Induction of eryptosis by cyclosporine. Naunyn Schmiedebergs Arch Pharmacol 2006;374:41-49.
31. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G Jr, Thornalley PJ, Schleicher E, Wieder T, Lang F: Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006;18:223-232.
32. Nicolay JP, Gatz S, Liebig G, Gulbins E, Lang F: Amyloid-induced suicidal erythrocyte death. Cell Physiol Biochem 2007;19:175-184.
33. Eisele K, Lang PA, Kempe DS, Klarl BA, Niemoller O, Wieder T, Huber SM, Duranton C, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by mercury ions. Toxicol Appl Pharmacol 2006;210:116-122.
34. Kempe DS, Lang PA, Eisele K, Klarl BA, Wieder T, Huber SM, Duranton C, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by lead ions. Am J Physiol 2005;288:C396-C402.
35. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, Lang F: Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007;13:164-170.
36. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C, Nammi S, Henke G, Myssina S, Krikov M, Huber SM, Wieder T, Lang F: Enhanced susceptibility to erythrocyte 'apoptosis' following phosphate depletion. Pflügers Arch 2004;448:471-477.
37. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, Lang F: Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-370.
38. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, Risler T, Baur M, Olbricht CJ, Zimmerhackl LB, Zipfel PF, Wieder T, Lang F: Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006;84:378-388.
39. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM, Lang F: Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 2003;13:347-356.
40. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, Wieder T: Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002;12:365-372.
41. Boas FE, Forman L, Beutler E: Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA 1998;95:3077-3081.
42. Arese P, Turrini F, Schwarzer E: Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005;16:133-146.
43. Barvitenko NN, Adragna NC, Weber RE: Erythrocyte signal transduction pathways, their oxygenation dependence and functional significance. Cell Physiol Biochem 2005;15:1-18.
44. Bosman GJ, Willekens FL, Werre JM: Erythrocyte aging: a more than superficial resemblance to apoptosis? Cell Physiol Biochem 2005;16:1-8.
45. Rice L, Alfrey CP: The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 2005;15:245-250.
46. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM: Binding of vascular anticoagulant α (VAC-α) to planar phospholipid bilayers. J Biol Chem 1990;265:4923-4928.
47. Bieberich E, MacKinnon S, Silva J, Noggle S, Condie BG: Regulation of cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous ceramide. J Cell Biol 2003;162:469-479.
48. Grassme H, Jendrossek V, Bock J, Riehle A, Gulbins E: Ceramide-rich membrane rafts mediate CD40 clustering. J Immunol 2002;168:298-307.
49. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M, Eisele K, Podolski M, Huber SM, Wieder T, Lang F: Protein kinase C mediates erythrocyte 'programmed cell death' following glucose depletion. Am J Physiol 2006;290:C244-C253.
50. De la Torre A, Granero S, Mayayo E, Corbella J, Domingo JL: Effect of age on vanadium nephrotoxicity in rats. Toxicol Lett 1999;105:75-82.
51. 2+ pathway in human red cells. Cell Biol Int 2003;27:903-912.
52. Benabe JE, Echegoyen LA, Pastrana B, Martinez-Maldonado M: Mechanism of inhibition of glycolysis by vanadate. J Biol Chem 1987;262:9555-9560.
53. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000;405:85-90.
54. Scibior A, Zaporowska H, Ostrowski J: Selected haematological and biochemical parameters of blood in rats after subchronic administration of vanadium and/or magnesium in drinking water. Arch Environ Contam Toxicol 2006;51:287-295.
55. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F: Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 2003;14:2750-2757.
56. Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A: Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 1999;10:1982-1990.